Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1980 Apr;4:191–194.

The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model.

D Raghavan, J Gibbs, R Nogueira Costa, J Kohn, A H Orr, A Barrett, M J Peckham
PMCID: PMC2149231  PMID: 6158975

Abstract

Although useful in the management of malignant testicular tumours, alphafoetoprotein and human chromonic gonadotrophin are not perfect parameters of tumour bulk. In a series of 65 patients with marker-positive advanced disease, 23 showed the phenomenon of discordance of markers or dissociation from tumour response. Transplantable human malignant teratoma xenografts were established in immune-suppressed mice as models of the human disease. In the model system, it was demonstrated that tumour AFP concentration was reflected by AFP titres in the blood, but that tumour AFP (or blood AFP) did not correlate well with tumour size. One xenograft line illustrated the evolution of marker-negative tumour cells from a patient who was initially AFP-positive.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagshawe K. D. Recent observations related to the chemotherapy and immunology of gestational choriocarcinoma. Adv Cancer Res. 1973;18:231–263. doi: 10.1016/s0065-230x(08)60754-x. [DOI] [PubMed] [Google Scholar]
  2. Heyderman E., Neville A. M. A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol. 1977 Feb;30(2):138–140. doi: 10.1136/jcp.30.2.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Peckham M. J., McElwain T. J., Barrett A., Hendry W. F. Combined management of malignant teratoma of the testis. Lancet. 1979 Aug 11;2(8137):267–270. doi: 10.1016/s0140-6736(79)90288-5. [DOI] [PubMed] [Google Scholar]
  4. Peckham M. J., McElwain T. J. Testicular tumours. Clin Endocrinol Metab. 1975 Nov;4(3):665–692. doi: 10.1016/s0300-595x(75)80052-1. [DOI] [PubMed] [Google Scholar]
  5. Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Testicular germ-cell neoplasms: recent advances in diagnosis and therapy. Ann Intern Med. 1979 Mar;90(3):373–385. doi: 10.7326/0003-4819-90-3-373. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES